UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Ultrasonographic evaluation of knee joint synovitis in two patients with palindromic rheumatism

Modern rheumatology, 2002-09, Vol.12 (3), p.230-234

2002

Link zum Volltext

Verfügbarkeit prüfen

Balance in a rotating artificial gravity environment

Experimental brain research, 2003-01, Vol.148 (2), p.266-271

2003

Link zum Volltext

Verfügbarkeit prüfen

Cloning of formate dehydrogenase gene from a methanol-utilizing bacterium Mycobacterium vaccae N10

Applied microbiology and biotechnology, 1995-12, Vol.44 (3-4), p.479-483

1995

Link zum Volltext

Verfügbarkeit prüfen

Mössbauer spectroscopic characterization of iron methyl pyropheophorbide a and its derivatives

Hyperfine interactions, 1994-12, Vol.91 (1), p.815-819

1994

Link zum Volltext

Verfügbarkeit prüfen

Ultrasonographic evaluation of knee joint synovitis in two patients with palindromic rheumatism

Modern rheumatology, 2002-09, Vol.12 (3), p.0230

2002

Link zum Volltext

Verfügbarkeit prüfen

Adsorption of lipoprotein containing apolipoprotein-B through plasma separation for treatment of familial hypercholesterolemia

International journal of artificial organs, 1986-09, Vol.9 (5), p.343

1986

Link zum Volltext

Verfügbarkeit prüfen

Effects of age on behavioral responses to dopamine agonists in the rat

European journal of pharmacology, 1987-06, Vol.138 (1), p.101-106

1987

Link zum Volltext

Verfügbarkeit prüfen

Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies

Journal of thrombosis and haemostasis, 2018-07, Vol.16 (7), p.1383-1390

2018

Link zum Volltext

Verfügbarkeit prüfen

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab

Journal of thrombosis and haemostasis, 2018-06, Vol.16 (6), p.1078-1088

2018

Link zum Volltext

Verfügbarkeit prüfen

Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI‐deficient plasma in vitro

Journal of thrombosis and haemostasis, 2019-01, Vol.17 (1), p.126-137

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti‐factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation

Journal of thrombosis and haemostasis, 2014-02, Vol.12 (2), p.206-213

2014

Link zum Volltext

Verfügbarkeit prüfen

PB2019: EFFICACY AND SAFETY OF IXAZOMIB PLUS LENALIDOMIDE AND DEXAMETHASONE FOLLOWING INJECTABLE PROTEASOME INHIBITOR-BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1890-1891

2022

Link zum Volltext

Verfügbarkeit prüfen

Optical coherence tomography in coronary atherosclerosis assessment and intervention

Nature reviews cardiology, 2022-10, Vol.19 (10), p.684-703

2022

Link zum Volltext

Verfügbarkeit prüfen

PARADIGM study: A multicenter, randomized, phase III study of mFOLFOX6 plus panitumumab or bevacizumab as first-line treatment in patients with RAS (KRAS/NRAS) wild-type metastatic colorectal cancer

Annals of oncology, 2019-07, Vol.30, p.iv10-iv10

2019

Link zum Volltext

Verfügbarkeit prüfen

Influence of chewing force on salivary stress markers as indicator of mental stress

Journal of oral rehabilitation, 2012-04, Vol.39 (4), p.261-269

2012

Link zum Volltext

Verfügbarkeit prüfen

90MO Panitumumab (PAN) vs bevacizumab (BEV) in metastatic colorectal cancer (mCRC) by microsatellite stable (MSS), RAS/BRAF, and HER2 amplification (HER2amp) status: Phase III PARADIGM biomarker study

Annals of oncology, 2023-11, Vol.34, p.S1503-S1504

2023

Link zum Volltext

Verfügbarkeit prüfen

Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery

Journal of thrombosis and haemostasis, 2006-07, Vol.4 (7), p.1496-1501

2006

Link zum Volltext

Verfügbarkeit prüfen

388P Early tumor shrinkage (ETS) and depth of response (DpR) analyses in metastatic colorectal cancer (mCRC) treated with first-line mFOLFOX6 plus panitumumab (PAN) or bevacizumab (BEV): Results from the phase III PARADIGM trial

Annals of oncology, 2022-09, Vol.33, p.S714

2022

Link zum Volltext

Verfügbarkeit prüfen

Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation

Thrombosis and haemostasis, 2011-11, Vol.106 (5), p.893

2011

Link zum Volltext

Verfügbarkeit prüfen

LBA O-10 First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results

Annals of oncology, 2022-06, Vol.33, p.S377

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study

Annals of oncology, 2018-06, Vol.29, p.v71-v71

2018

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of factor VIIa‐catalyzed activation of factor VIII

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2494-2503

2010

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular risk factors and underlying pathology and prevalence of lipid plaques in women with acute coronary syndromes in different age groups

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 121

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(106)

Publikationsform

Artikel
(120)
Berichte
(1)

Sprache

Englisch
(121)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(68)
Humans
(46)
Biological And Medical Sciences
(36)
Animals
(29)
Male
(29)
Female
(25)
Medical Sciences
(24)
Fundamental And Applied Biological Sciences. Psychology
(16)
Adult
(14)
Middle Aged
(14)
Cardiovascular System & Cardiology
(12)
Aged
(11)
Pharmacology & Pharmacy
(11)
Base Sequence
(10)
Biochemistry & Molecular Biology
(10)
Rats
(10)
Hematology
(9)
Surgery
(9)
General Medicine
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ultrasonographic evaluation of knee joint synovitis in two patients with palindromic rheumatism

Balance in a rotating artificial gravity environment

Cloning of formate dehydrogenase gene from a methanol-utilizing bacterium Mycobacterium vaccae N10

Mössbauer spectroscopic characterization of iron methyl pyropheophorbide a and its derivatives

Ultrasonographic evaluation of knee joint synovitis in two patients with palindromic rheumatism

Adsorption of lipoprotein containing apolipoprotein-B through plasma separation for treatment of familial hypercholesterolemia

Effects of age on behavioral responses to dopamine agonists in the rat

Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab

Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI‐deficient plasma in vitro

Anti‐factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation

PB2019: EFFICACY AND SAFETY OF IXAZOMIB PLUS LENALIDOMIDE AND DEXAMETHASONE FOLLOWING INJECTABLE PROTEASOME INHIBITOR-BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Optical coherence tomography in coronary atherosclerosis assessment and intervention

PARADIGM study: A multicenter, randomized, phase III study of mFOLFOX6 plus panitumumab or bevacizumab as first-line treatment in patients with RAS (KRAS/NRAS) wild-type metastatic colorectal cancer

Influence of chewing force on salivary stress markers as indicator of mental stress

90MO Panitumumab (PAN) vs bevacizumab (BEV) in metastatic colorectal cancer (mCRC) by microsatellite stable (MSS), RAS/BRAF, and HER2 amplification (HER2amp) status: Phase III PARADIGM biomarker study

Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery

The DNA sequence of human chromosome 21

388P Early tumor shrinkage (ETS) and depth of response (DpR) analyses in metastatic colorectal cancer (mCRC) treated with first-line mFOLFOX6 plus panitumumab (PAN) or bevacizumab (BEV): Results from the phase III PARADIGM trial

127P A meta-analysis of efficacy and safety from head-to-head first-line (1L) trials of epidermal growth factor receptor inhibitors (EGFRIs) versus bevacizumab in combination with chemotherapy (CT) doublets in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) by sidedness

Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation

LBA O-10 First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results

A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study

Mechanisms of factor VIIa‐catalyzed activation of factor VIII

Cardiovascular risk factors and underlying pathology and prevalence of lipid plaques in women with acute coronary syndromes in different age groups

Aktive Filter

Suchergebnisse filtern